EP Patent

EP1961735B1 — Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt

Assigned to Indena SpA · Expires 2009-11-18 · 16y expired

What this patent protects

A process for the enantioselective preparation of (2 R ,3 S )-3-phenylisoserine methyl ester acetate salt of formula (I) which is an useful building block for the synthesis of taxane derivatives. The process involves the resolution of racemic threo-phenylisoserine amide and i…

USPTO Abstract

A process for the enantioselective preparation of (2 R ,3 S )-3-phenylisoserine methyl ester acetate salt of formula (I) which is an useful building block for the synthesis of taxane derivatives. The process involves the resolution of racemic threo-phenylisoserine amide and its conversion into (I).

Drugs covered by this patent

Patent Metadata

Patent number
EP1961735B1
Jurisdiction
EP
Classification
Expires
2009-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Indena SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.